Corcept Therapeutics shares surge as lead drug gets FDA nod for ovarian cancer | Reuters Skip to main content Exclusive news, data and analytics for financial market professionalsLearn more aboutRefinitiv A view shows the U.S. Food and Drug Administration (FDA) headquarters in Silver Spring, Maryland August 14, 2012. Picture taken August 14, 2012. REUTERS/Jason Reed Purchase Licensing Rights, opens new tab Companies Corcept Therapeutics Inc Follow Merck & Co Inc Follow U.S. Food and Drug Administration Foll ...